Pituitary adenomas are common neoplasms. Their classification is based upon size,
invasion of adjacent structures, sporadic or familial cases, biochemical activity, clinical …

Long noncoding RNAs (lncRNAs) and their crosstalks with other RNAs have been revealed
to be closely related to tumorigenesis and development, but their role in invasive pituitary …

Pituitary neuroendocrine tumors (PitNET) are common intracranial neoplasms. While in case
of hormone secreting tumors pituitary hormone measurements can be used for monitoring …

Cytotoxic T lymphocyte-associated protein 4 (CTLA4), a negative regulator typically
expressed on the surface of T lymphocytes, is targeted by immunotherapy in patients with an …

Background Personalized postoperative management of patients with pituitary adenomas
requires an early risk stratification system. Methods We reviewed 501 cases operated …

Background Pituitary adenoma (PA) is a benign neuroendocrine tumor caused by
adenohypophysial cells, and accounts for 10%-20% of all primary intracranial tumors. The …

Pituitary carcinoma (PC) is a very rare tumor entity of the sella turcica, representing 0.1–
0.5% of all PitNETs tumors [1–5]. Based on the WHO Classification, it is defined as pituitary …

Purpose Although well-documented from pathological aspect, the clinical features and
outcomes of acromegaly with mammosomatotroph (MSA) and mixed somatotroph-lactotroph …

SOX2 positive pituitary stem cells (PSCs) are specified embryonically and persist throughout
life, giving rise to all pituitary endocrine lineages. We have previously shown the activation …

Object: This study aimed to explore the relationship between the aggressiveness and
immune cell infiltration in pituitary adenoma (PA) and to provide the basis for immuno …